Adaptive Biotechnologies Corp. (ADPT)
16.03
+0.17
(+1.07%)
USD |
NASDAQ |
Feb 10, 10:29
Adaptive Biotechnologies Market Cap : 2.465B for Feb. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 155.73B |
| Gilead Sciences, Inc. | 186.88B |
| Regeneron Pharmaceuticals, Inc. | 81.62B |
| Recursion Pharmaceuticals, Inc. | 2.108B |
| Arcellx, Inc. | 3.906B |
Market Cap Related Metrics
| PS Ratio | 8.935 |
| Price to Book Value | 11.27 |
| Price | 16.03 |
| Earnings Yield | -2.49% |